Exciting News in Cancer Treatment: OncoC4 Announces Phase 2 Combination Trial Breaking Ground in Cancer Research The Phase 2 multicenter, open-label combination trial by OncoC4, Inc. marks a significant advancement in the field of cancer treatment. This new trial builds upon the promising results of ONC-392 seen in previous clinical trials, offering hope to patients…
KULR Technology Group to Virtually Participate at the 25th Annual Needham Growth Conference on January 12, 2023 SAN DIEGO, Dec. 30, 2022 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE: KULR) (“the Company” or “KULR”), a leading energy management platform company accelerating the global transition to a sustainable electrification economy, is scheduled to virtually participate…
FarmBot Ships Record Number of Farming Robots to Homeowners and Schools, Bringing the Smart Home Revolution to Life The Future of Farming The machines, heralded as “3D printers for the garden”, automatically plant seeds, water, detect and remove weeds, and measure soil properties. FarmBot Express and Express XL FarmBot Express and Express XL SAN LUIS…
Welcome to the World of Reduced Iron Powder Market Sales in North America to Register 38% CAGR by 2033 Are you ready to dive into the fascinating world of reduced iron powder? Well, get ready because the sales in North America are expected to skyrocket with a whopping 38% CAGR between 2023 and 2033! This…
LEIDOS ALERT: Bragar Eagel & Squire, P.C. is Investigating Leidos Holdings Inc. on Behalf of Leidos Stockholders NEW YORK, Dec. 29, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Leidos Holdings Inc. (“Leidos” or the “Company”) (NYSE: LDOS) on behalf of Leidos…
Embracing Change: Navigating the F45 Training Holdings Inc. Class Action Lawsuit Take Action Before it’s Too Late As the deadline approaches for investors to file a lead plaintiff motion in the class action lawsuit against F45 Training Holdings Inc. (FXLV), it’s important to be informed and take action. Glancy Prongay & Murray LLP is reminding…
Unicycive Announces Termination of “At-The-Market” Offering of Shares of Co… Goodbye, ATM Offering! So long, farewell, ATM Offering! Unicycive Therapeutics, Inc. has decided to bid adieu to its “at-the-market” equity offering program. The company made the announcement that it’s pulling the plug on this program with JonesTrading Institutional Services, LLC as the sales agent. But…
Polylactic Acid Market Growth on the Rise The North America polylactic acid industry is expected to register a 10.7% CAGR between 2022 and 2032. The demand for polylactic acid is expected to grow at 12.8% CAGR between 2022 and 2032 in Europe. According to a recent research report, the Polylactic Acid (PLA) market is projected…
